Herzlich Willkommen auf der Homepage des Instituts für Pathophysiologie und Allergieforschung!
Gegründet im Jahr 1873 gehört das IPA zu den ältesten Forschungsinstituten der Medizinischen Universität Wien.
Derzeit haben wir 130 interdisziplinäre und internationale MitarbeiterInnen, deren Forschungsarbeit darauf abzielt, pathophysiologische Vorgänge besser zu verstehen und daraus innovative Konzepte zu entwickeln, die der Diagnose, Prophylaxe und Therapie von Erkrankungen dienen. Zusätzlich legen wir Wert auf höchste Qualität in der Lehre und Ausbildung von MedizinerInnen und NaturwissenschafterInnen. Darüber hinaus bietet das IPA die postgradualen
Ausbildungen zu FachärztInnen für Pathophysiologie und Immunologie an.
Research News
Mahbod A., Schaefer G., Ellinger I., Ecker R., Smedby Ö., Wang C. (2019) In: Reyes-Aldasoro C., Janowczyk A., Veta M., Bankhead P., Sirinukunwattana K. (eds) Digital Pathology. ECDP 2019. Lecture Notes in Computer Science, vol 11435. Springer, Cham
July 30, 2019, Nature Communications 10, 3298, by Jordakieva et al.: Antiacids drugs prime subsequent anti-allergy prescriptions. 30% of 30-years old, and 33% of 60-year old Austrians are treated with gastric acid-inhibitors. As a continuation of their previous works, the team around Erika Jensen-Jarolim performed a population-wide study in Austria and found a significant correlation between the intake of these drugs and symptoms of respiratory allergies, treated by H1R blockers and allergen-specific immunotherapy. See https://www.nature.com/articles/s41467-019-10914-6
News & Activities
Dr. Martin Schepelmann (research group of Assoc. Prof. Dr. Enikö Kallay) received a grant of € 418,000, co-funded from the Herzfelder Family Foundation and the FWF (Austrian Science Fund), for his project “Effect of ageing on a chemically induced colon cancer model”.
Gabriela Sanchez-Acosta and Christina Weichwald received oral presentation awards, Tanja Kalic and Verena Köhler got awarded poster discussion awards, Piotr Humeniuk and Christoph Nagl received poster prizes for their presentations at the annual congress of the European Academy for Allergy and Clinical Immunology (EAACI).
Pawel Dubiela, a former member from the MCCA PhD programme (Group Karin Hoffmann-Sommergruber), has received the “Best PhD Thesis award 2018” during the XI Training conference of the Polish Society of Allergology on May 8, 2019 in Wisla, Poland based on his outstanding achievements during his PhD Studies. Congratulations!
Schnellinfo
Featured
